IL17A and Alzheimer disease: GO function analysis and KEGG pathway analysis showed that the potential active components of MGD intervene in AD-related pathways by acting on disease targets, including pathways in cancer, lipid and atherosclerosis pathways, IL-17 signaling pathway, MAPK signaling pathway, etc. (Figures 2A,B).